- In August 2026, Northrop Grumman’s board declared a quarterly dividend of US$2.47 per share and, through Kratos Defense & Security Solutions, announced a U.S. Marine Corps MUX TACAIR contract to rapidly develop Missionized Valkyrie Air Vehicle prototypes, with the first aircraft targeted for completion in summer 2026.
- These developments, alongside management’s confidence in winning a meaningful share of the very large Golden Dome space-based missile defense program and ongoing expansion to meet rising defense demand, underscore how Northrop Grumman is tying near-term contract execution to its longer-term role in advanced autonomous and space-based deterrence systems.
- Next, we’ll examine how anticipated participation in the Golden Dome space-based missile defense program could reshape Northrop Grumman’s long-term investment narrative.
This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.
Northrop Grumman Investment Narrative Recap
To own Northrop Grumman, you need to believe sustained demand for advanced defense, space and autonomous systems will support durable cash generation despite heavy reliance on large U.S. programs. The latest dividend declaration and MUX TACAIR award modestly reinforce this thesis, but they do not materially change the near term focus on execution risk in big programs like B 21 and Sentinel, or the broader budget and political risk tied to U.S. defense spending.
The MUX TACAIR contract with the U.S. Marine Corps stands out here, because it directly links Northrop Grumman’s autonomy software and mission kits to a concrete, near term unmanned aircraft program. That matters for the current catalyst around advanced autonomous and integrated systems, which many investors see as an important counterweight to the company’s concentration in large, high cost hardware programs and the programmatic risks that come with them.
Yet, against this positive momentum, investors should also weigh how exposed Northrop Grumman remains if U.S. defense priorities or funding for key programs were to...
Read the full narrative on Northrop Grumman (it's free!)
Northrop Grumman's narrative projects $50.8 billion revenue and $4.7 billion earnings by 2029. This requires 5.8% yearly revenue growth and a $0.2 billion earnings increase from $4.5 billion today.
Uncover how Northrop Grumman's forecasts yield a $643.62 fair value, a 17% upside to its current price.
Exploring Other Perspectives
Three Simply Wall St Community valuations cluster tightly between US$643.62 and US$667.66 per share, showing how closely some private investors are sizing Northrop Grumman. Set that against the central risk that heavy dependence on large U.S. government contracts can amplify the impact of any program delays or budget shifts on future company performance, and you have a clear reason to explore several alternative viewpoints before deciding how this fits in your portfolio.
Explore 3 other fair value estimates on Northrop Grumman - why the stock might be worth just $643.62!
Form Your Own Verdict
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Northrop Grumman research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Northrop Grumman research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Northrop Grumman's overall financial health at a glance.
Searching For A Fresh Perspective?
Every day counts. These free picks are already gaining attention. See them before the crowd does:
- AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- Invest in the nuclear renaissance through our list of 92 elite nuclear energy infrastructure plays powering the global AI revolution.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com